NYSE$AMPE

Ampio Pharmaceuticals Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Headline financials

Total Revenue

$0.00

No prior period
EPS (adj)

-$0.01

Previous: -$0.00-250.0%
Capital Expenditures

$0.00

No prior period
Free Cash Flow

-$4.29M

Previous: -$3.7M-15.8%
Net Income

-$2.22M

Previous: -$6.22M+64.3%
Operating Income

-$2.7M

No prior period
Gross Profit

-$369K

No prior period
Cash & Equivalents

$12.7M

Previous: $33.9M-62.7%
Total Assets

$13.6M

Previous: $38.8M-65.0%
Stock-Based Comp

$669K

Previous: $2.44M-72.6%

Revenue & EPS history

Ampio · Revenue · Quarterly

$0

Q4 2022

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

-0.4%

Avg return

Earnings day

-3.9%

Avg return

5 days after

-17.0%

Avg return

30 days after

31%

10 / 32 earnings

Positive

+32.5%

Q1 2011

Best reaction

-20.0%

Q4 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2023+13.4%-2.2%-60.4%
Q3 2023+6.2%+0.1%-21.1%
Q2 2023+4.8%-0.3%+3.0%
Q1 2023-8.3%-8.9%-3.5%
Q4 2022+4.0%-6.8%-16.9%
Q3 2022-18.9%+8.1%-25.8%
Q3 2024-10.3%-31.0%-46.0%
Q2 2022-9.1%-4.5%-15.9%
Q1 2022+0.0%-1.7%-50.0%
Q4 2021-8.0%-7.7%-57.2%
Q3 2021-14.7%-19.6%-39.2%
Q2 2021+9.8%+13.6%+28.8%
Q1 2021+12.8%+7.9%-99.6%
Q4 2020-5.5%-10.9%+12.1%
Q3 2020+1.2%-6.4%+27.4%
Q2 2020-1.9%+0.9%-30.4%
Q1 2020+23.3%+14.6%+42.9%
Q3 2019-7.7%-7.3%+7.1%
Q1 2019+0.0%-5.8%+1.4%
Q4 2018-8.8%-16.2%-24.7%
Q3 2018-1.7%-1.5%-31.5%
Q2 2018-2.1%+0.6%+26.3%
Q3 2015
Q2 2015
Q3 2012-4.7%
Q1 2012-0.4%
Q4 2011-2.6%
Q3 2011-4.9%
Q2 2011-1.3%
Q1 2011+32.5%
Q4 2010-20.0%
Q3 2010-3.3%
Q2 2010+27.3%
Q1 2010-14.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro